Jaguar health to present september 19 at the medinvest biotech & pharma investor conference

San francisco, ca / accesswire / september 16, 2024 / jaguar health, inc. (nasdaq:jagx) today announced that lisa conte, the company's founder, president and ceo, will present in person on september 19, 2024 at the medinvest biotech & pharma investor conference and participate in one-on-one meetings at the event, which is taking place september 18-19 in new york city. participation instructions for jaguar health's presentation at the medinvest biotech & pharma investor conference when: thursday, september 19, 2024 from 9:55 am eastern to 10:10 am eastern registration link for presentation: click here about the jaguar health family of companies jaguar health, inc. (jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain.
JAGX Ratings Summary
JAGX Quant Ranking